Global Intracardiac Echocardiography (ICE) Catheter Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Intracardiac Echocardiography (ICE) Catheter Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Echocardiography uses ultrasound waves to make picture of structures inside the heart. Intracardiac echocardiogram (ICE) is a catheter-based form of echocardiography that gathers images from within the heart, rather than by gathering images of the heart by sending sound waves through the chest wall. Intracardiac Echocardiography (ICE) Catheter is used in this process. This report studies the global Intracardiac Echocardiography (ICE) Catheter market.

Market Overview:

The latest research study on the global Intracardiac Echocardiography (ICE) Catheter market finds that the global Intracardiac Echocardiography (ICE) Catheter market reached a value of USD 523.75 million in 2022. It’s expected that the market will achieve USD 764.51 million by 2028, exhibiting a CAGR of 6.51% during the forecast period.

The production and sales of Intracardiac Echocardiography (ICE) Catheter are affected by Covid-19

In order to curb the COVID-19 epidemic, most countries have introduced many policies, including border blockade and social distancing. The epidemic prevention and control measures will affect the flow of people and activities, and in turn affect logistics, making the production of manufacturing, affected by the supply of raw materials and labor shortages.
For the Intracardiac Echocardiography (ICE) Catheter industry, the blockade policy will affect the supply of raw materials and export trade of products. The social distancing policy may have a great impact on the production of products, especially for some factories, they will spend more money to maintain production during the epidemic, and factories may face the risk of closure in some areas. With the gradual control of the epidemic, some factories began to resume operation. However, while operating production, enterprises need to protect the life and health of employees, such as purchasing masks, disinfectants and other epidemic prevention materials, disinfecting the working environment before and after the production, and testing the body temperature of employees every day to ensure the health of employees. These measures will increase the production cost of enterprises and affect the development of enterprises.
But in the long term, the COVID-19 outbreak may cause more factories to start using more automated production lines to avoid the pandemic's impact on the industry. In addition, the application of IoT technology may also bring more opportunities for industry participants.

The advantage of Intracardiac Echocardiography (ICE)

Intracardiac Echocardiography (ICE) uses a catheter-based cardiac ultrasound array to image anatomy and devices inside the heart to help guide surgery. ICE is mainly used in electrophysiology (EP) lab ablation procedures and transcatheter structural heart interventions. Both transthoracic (TTE) and transesophageal echocardiography (TEE) are used to guide transcatheter interventions, but they both have limitations. ICE offers the advantage of imaging from inside the heart, providing shorter image distance and higher resolution. ICE can be performed without sedation, avoiding esophageal intubation like TEE. The advantage of ICE is an important factor to promote the demand growth of downstream field, thus promoting the application of Intracardiac Echocardiography (ICE) Catheter.

The barriers to entry into the medical device industry are relatively high

In addition to meeting the general laws and regulations, enterprises in this industry should have the prescribed operating conditions, including legally qualified medical technicians, engineering technicians and corresponding technical workers; It shall have factory buildings, facilities and a hygienic environment suitable for the production of medical device; It has an organization, personnel and necessary instruments and equipment capable of conducting quality control and quality inspection of the medical device produced; There are rules and regulations to ensure the quality of medical device. Medical device industry is a high investment industry, its new product development investment is high, the cycle is long, the risk is big. Therefore, new entrants usually need a long time to start up and face great financial pressure. Medical device industry technology is difficult, high equipment requirements, complex process route, production environment requirements are very strict.

Region Overview:

Geographically, North America held the largest market share – 48.44% in 2022.

Company Overview:

Abbott is one of the major players operating in the Intracardiac Echocardiography (ICE) Catheter market, holding a share of 40.9% in 2022.

Abbott

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines.

Siemens

Siemens AG is a German multinational conglomerate corporation and the largest industrial manufacturing company in Europe headquartered in Munich with branch offices abroad.

Segmentation Overview:

By type, 2D segment accounted for the largest share of market in 2022.

2D

Contemporary two-dimensional (2D) ICE catheters have a diameter of 8Fr and a length of 90 cm.

3D/4D

Three-dimensional (3D) ICE catheters have a diameter up to 12.5 Fr and are 90 cm in length. 3D ICE catheters provide a 90° imaging sector. The new 4D echo catheter, which is small enough to be inserted into the heart chambers, uses advanced imaging technology to create high-quality 3D moving images. This technology allows physicians to see structures and blood flow in live motion inside the heart, which is a major improvement over the standard intracardiac echo catheters that are only capable of providing 2D images. The 4D technology provides greater visual details to guide interventional heart procedures, such as left atrial appendage closure, mitral valve repair and treatment of tricuspid valve regurgitation.

Application Overview:

The market's largest segment by application is the segment Cardiac Electrophysiological Therapy, with a market share of 53.36% in 2022.

Key Companies in the global Intracardiac Echocardiography (ICE) Catheter market covered in Chapter 3:

Koninklijke Philips
Siemens
Boston Scientific
Johnson & Johnson MedTech
Abbott

In Chapter 4 and Chapter 14.2, on the basis of types, the Intracardiac Echocardiography (ICE) Catheter market from 2018 to 2029 is primarily split into:

2D
3D/4D

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Intracardiac Echocardiography (ICE) Catheter market from 2018 to 2029 covers:

Cardiac Electrophysiological Therapy
Minimally Invasive Treatment of Valve Disease
Congenital Heart Disease Occlusion Treatment
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)